Turning Point Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/08/2022 | Q2 2022 | -$1.70 | -$2.48 | -0.78 | $119,000 | |
| 05/10/2022 | Q1 2022 | -$1.51 | -$1.50 | 0.01 | $429,000 | |
| 02/28/2022 | Q4 2021 | -$1.39 | -$1.58 | -0.19 | $25,205 | |
| 11/09/2021 | Q3 2021 | -$1.27 | -$1.34 | -0.07 | $460,000 | |
| 08/09/2021 | Q2 2021 | -$1.21 | -$1.14 | 0.07 | $5.16 M | |
| 05/05/2021 | Q1 2021 | -$0.61 | -$0.73 | -0.12 | $25.21 M | |
| 03/01/2021 | Q4 2020 | -$0.92 | -$1.02 | -0.1 | $0 | |
| 11/12/2020 | Q3 2020 | -$0.54 | -$0.42 | 0.12 | $25.00 M | |
| 08/10/2020 | Q2 2020 | -$0.89 | -$0.82 | 0.07 | $0 | |
| 05/12/2020 | Q1 2020 | -$0.66 | -$1.69 | -1.03 | $0 | |
| 03/17/2020 | Q4 2019 | -$0.58 | $0 | |||
| 11/04/2019 | Q3 2019 | -$0.55 | -$0.63 | -0.08 | $0 | |
| 08/06/2019 | Q2 2019 | -$0.65 | -$0.70 | -0.05 | $0 | |
| 05/31/2019 | Q1 2019 | -$0.69 | -$0.49 | 0.2 | $0 | |
| 12/30/2018 | Q4 2018 | -$0.32 | $0 | |||
| 09/29/2018 | Q3 2018 | -$0.40 | $0 | |||
| 06/29/2018 | Q2 2018 | -$0.34 | $0 | |||
| 03/30/2018 | Q1 2018 | -$0.32 | $0 |
Turning Point Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Turning Point Therapeutics, Inc.'s earnings date?
Turning Point Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 8th, 2022 based off last year's report dates.
-
How can I listen to Turning Point Therapeutics, Inc.'s earnings conference call?
The conference call for Turning Point Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Turning Point Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Turning Point Therapeutics, Inc.'s latest earnings report can be read online.
-
How much revenue does Turning Point Therapeutics, Inc. generate each year?
Turning Point Therapeutics, Inc. (:TPTX) has a recorded annual revenue of $30.83 M.
-
How much profit does Turning Point Therapeutics, Inc. generate each year?
Turning Point Therapeutics, Inc. (:TPTX) has a recorded net income of $30.83 M. Turning Point Therapeutics, Inc. has generated $-5.79 earnings per share over the last four quarters.
-
What is Turning Point Therapeutics, Inc.'s price-to-earnings ratio?
Turning Point Therapeutics, Inc. (:TPTX) has a price-to-earnings ratio of -13.03 and price/earnings-to-growth ratio is 0.26.
